Morgan Biopharma’s operations are built on a strong foundation of compliance with Vietnam’s national health regulatory framework, in which the Ministry of Health (MOH) plays a central role in policy development, licensing, and overall oversight of pharmaceutical and health-related activities. MOH supervision ensures that all research, production, and commercialization activities align with national regulations and internationally harmonized standards adopted by Vietnam.

Within this framework, the Drug Administration of Vietnam (DAV) serves as a key authority responsible for the evaluation, licensing, and supervision of medicinal products, raw materials, quality standards, and compliance with good practices such as GMP, GSP, and GDP. DAV regulations and guidance form the basis upon which Morgan Biopharma structures its operational processes, quality systems, and regulatory documentation in a consistent and transparent manner.

In parallel, the Vietnam Food Administration (VFA) oversees the licensing and regulatory control of health supplements and natural ingredient–based products within the food safety domain. Together, MOH, DAV, and VFA create an integrated regulatory ecosystem that safeguards public health while ensuring market transparency. Morgan Biopharma positions adherence to this regulatory oversight as the cornerstone of its operations, demonstrating a firm commitment to responsible, lawful, and sustainable practices in Vietnam and beyond.